Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and medical or pharmacy claims to genomic, behavioral and sensor data. Yet it can be ...
When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.
UC Berkeley School of Public Health researchers are collaborating with the FDA and industry to make drug clinical trials ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
OneMedNet Corporation (Nasdaq: ONMD) (the 'OneMedNet,” the 'Company,” 'we,” 'us” or 'our”), a leading provider of regulatory ...
The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct ...
Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...
The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how ...
Every clinical trial is built on the promise that the risk is justified by the strength of the evidence supporting it.
Many challenges face developers of drugs for rare diseases, including the small number of patients available for clinical trials, genotypic and phenotypic diversity within a disorder, poorly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results